Does TREPROSTINIL Cause Infusion site mass? 119 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 119 reports of Infusion site mass have been filed in association with TREPROSTINIL (TYVASO). This represents 0.1% of all adverse event reports for TREPROSTINIL.
119
Reports of Infusion site mass with TREPROSTINIL
0.1%
of all TREPROSTINIL reports
2
Deaths
25
Hospitalizations
How Dangerous Is Infusion site mass From TREPROSTINIL?
Of the 119 reports, 2 (1.7%) resulted in death, 25 (21.0%) required hospitalization.
Is Infusion site mass Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 119 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Infusion site mass?
HUMAN IMMUNOGLOBULIN G (387)
BACLOFEN (92)
FOSCARBIDOPA\FOSLEVODOPA (42)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (41)
HYDROMORPHONE (33)
BUPIVACAINE (23)
INSULIN LISPRO-AABC (20)
CLONIDINE (19)
FENTANYL (19)
INSULIN LISPRO (18)
Which TREPROSTINIL Alternatives Have Lower Infusion site mass Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE